Correlation Between Pasithea Therapeutics and Champions Oncology
Can any of the company-specific risk be diversified away by investing in both Pasithea Therapeutics and Champions Oncology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pasithea Therapeutics and Champions Oncology into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Pasithea Therapeutics Corp and Champions Oncology, you can compare the effects of market volatilities on Pasithea Therapeutics and Champions Oncology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pasithea Therapeutics with a short position of Champions Oncology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pasithea Therapeutics and Champions Oncology.
Diversification Opportunities for Pasithea Therapeutics and Champions Oncology
-0.51 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Pasithea and Champions is -0.51. Overlapping area represents the amount of risk that can be diversified away by holding Pasithea Therapeutics Corp and Champions Oncology in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Champions Oncology and Pasithea Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pasithea Therapeutics Corp are associated (or correlated) with Champions Oncology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Champions Oncology has no effect on the direction of Pasithea Therapeutics i.e., Pasithea Therapeutics and Champions Oncology go up and down completely randomly.
Pair Corralation between Pasithea Therapeutics and Champions Oncology
Assuming the 90 days horizon Pasithea Therapeutics Corp is expected to generate 65.03 times more return on investment than Champions Oncology. However, Pasithea Therapeutics is 65.03 times more volatile than Champions Oncology. It trades about 0.22 of its potential returns per unit of risk. Champions Oncology is currently generating about -0.03 per unit of risk. If you would invest 1.30 in Pasithea Therapeutics Corp on August 28, 2024 and sell it today you would earn a total of 0.73 from holding Pasithea Therapeutics Corp or generate 56.15% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 50.72% |
| Values | Daily Returns |
Pasithea Therapeutics Corp vs. Champions Oncology
Performance |
| Timeline |
| Pasithea Therapeutics |
| Champions Oncology |
Pasithea Therapeutics and Champions Oncology Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Pasithea Therapeutics and Champions Oncology
The main advantage of trading using opposite Pasithea Therapeutics and Champions Oncology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pasithea Therapeutics position performs unexpectedly, Champions Oncology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Champions Oncology will offset losses from the drop in Champions Oncology's long position.| Pasithea Therapeutics vs. Eliem Therapeutics | Pasithea Therapeutics vs. HCW Biologics | Pasithea Therapeutics vs. Scpharmaceuticals | Pasithea Therapeutics vs. Milestone Pharmaceuticals |
| Champions Oncology vs. Fonar | Champions Oncology vs. Burning Rock Biotech | Champions Oncology vs. Sera Prognostics | Champions Oncology vs. Exagen Inc |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bollinger Bands module to use Bollinger Bands indicator to analyze target price for a given investing horizon.
Other Complementary Tools
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments |